Genomic loss of heterozygosity and survival in the REAL3 trial.
Saved in:
| Title: | Genomic loss of heterozygosity and survival in the REAL3 trial. |
|---|---|
| Authors: | Smyth EC; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom.; Current affiliation: Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Cafferkey C; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom., Loehr A; Clovis Oncology, San Francisco, CA, United States of America., Waddell T; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom.; Current affiliation: Department of Medical Oncology, Christie Hospital, Manchester, United Kingdom., Begum R; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom., Peckitt C; Department of Clinical Research & Development, Royal Marsden Hospital, London & Sutton, United Kingdom., Harding TC; Clovis Oncology, San Francisco, CA, United States of America., Nguyen M; Clovis Oncology, San Francisco, CA, United States of America., Okines AF; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom., Raponi M; Clovis Oncology, San Francisco, CA, United States of America., Rao S; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom., Watkins D; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom., Starling N; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom., Middleton GW; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Wadsley J; Department of Medical Oncology, Weston Park Hospital, Sheffield, United Kingdom., Mansoor W; Current affiliation: Department of Medical Oncology, Christie Hospital, Manchester, United Kingdom., Crosby T; Department of Clinical Oncology, Velindre Hospital, Cardiff, Wales, United Kingdom., Wotherspoon A; Department of Histopathology, Royal Marsden Hospital, London & Surrey, United Kingdom., Chau I; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom., Cunningham D; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom. |
| Source: | Oncotarget [Oncotarget] 2018 Nov 30; Vol. 9 (94), pp. 36654-36665. Date of Electronic Publication: 2018 Nov 30 (Print Publication: 2018). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30613349 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Genomic loss of heterozygosity and survival in the REAL3 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Smyth+EC%22">Smyth EC</searchLink>; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom.; Current affiliation: Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Cafferkey+C%22">Cafferkey C</searchLink>; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Loehr+A%22">Loehr A</searchLink>; Clovis Oncology, San Francisco, CA, United States of America.<br /><searchLink fieldCode="AU" term="%22Waddell+T%22">Waddell T</searchLink>; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom.; Current affiliation: Department of Medical Oncology, Christie Hospital, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Begum+R%22">Begum R</searchLink>; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Peckitt+C%22">Peckitt C</searchLink>; Department of Clinical Research & Development, Royal Marsden Hospital, London & Sutton, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Harding+TC%22">Harding TC</searchLink>; Clovis Oncology, San Francisco, CA, United States of America.<br /><searchLink fieldCode="AU" term="%22Nguyen+M%22">Nguyen M</searchLink>; Clovis Oncology, San Francisco, CA, United States of America.<br /><searchLink fieldCode="AU" term="%22Okines+AF%22">Okines AF</searchLink>; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Raponi+M%22">Raponi M</searchLink>; Clovis Oncology, San Francisco, CA, United States of America.<br /><searchLink fieldCode="AU" term="%22Rao+S%22">Rao S</searchLink>; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Watkins+D%22">Watkins D</searchLink>; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Starling+N%22">Starling N</searchLink>; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Middleton+GW%22">Middleton GW</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wadsley+J%22">Wadsley J</searchLink>; Department of Medical Oncology, Weston Park Hospital, Sheffield, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Mansoor+W%22">Mansoor W</searchLink>; Current affiliation: Department of Medical Oncology, Christie Hospital, Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Crosby+T%22">Crosby T</searchLink>; Department of Clinical Oncology, Velindre Hospital, Cardiff, Wales, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wotherspoon+A%22">Wotherspoon A</searchLink>; Department of Histopathology, Royal Marsden Hospital, London & Surrey, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Chau+I%22">Chau I</searchLink>; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Cunningham+D%22">Cunningham D</searchLink>; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101532965%22">Oncotarget</searchLink> [Oncotarget] 2018 Nov 30; Vol. 9 (94), pp. 36654-36665. <i>Date of Electronic Publication: </i>2018 Nov 30 (<i>Print Publication: </i>2018). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Impact+Journals%22">Impact Journals </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101532965 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1949-2553 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219492553%22">19492553 </searchLink><i>NLM ISO Abbreviation: </i>Oncotarget <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30613349 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.18632/oncotarget.26336 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 36654 Titles: – TitleFull: Genomic loss of heterozygosity and survival in the REAL3 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Smyth EC – PersonEntity: Name: NameFull: Cafferkey C – PersonEntity: Name: NameFull: Loehr A – PersonEntity: Name: NameFull: Waddell T – PersonEntity: Name: NameFull: Begum R – PersonEntity: Name: NameFull: Peckitt C – PersonEntity: Name: NameFull: Harding TC – PersonEntity: Name: NameFull: Nguyen M – PersonEntity: Name: NameFull: Okines AF – PersonEntity: Name: NameFull: Raponi M – PersonEntity: Name: NameFull: Rao S – PersonEntity: Name: NameFull: Watkins D – PersonEntity: Name: NameFull: Starling N – PersonEntity: Name: NameFull: Middleton GW – PersonEntity: Name: NameFull: Wadsley J – PersonEntity: Name: NameFull: Mansoor W – PersonEntity: Name: NameFull: Crosby T – PersonEntity: Name: NameFull: Wotherspoon A – PersonEntity: Name: NameFull: Chau I – PersonEntity: Name: NameFull: Cunningham D IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 11 Text: 2018 Nov 30 Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 1949-2553 Numbering: – Type: volume Value: 9 – Type: issue Value: 94 Titles: – TitleFull: Oncotarget Type: main |
| ResultId | 1 |